Quantitative magnetic resonance imaging predicts individual future liver performance after liver resection for cancer
Damian J Mole, Jonathan A Fallowfield, Ahmed E Sherif, Timothy Kendall, Scott Semple, Matt Kelly, Gerard Ridgway, John J Connell, John McGonigle, Rajarshi Banerjee, J Michael Brady, Xiaozhong Zheng, Michael Hughes, Lucile Neyton, Joanne McClintock, Garry Tucker, Hilary Nailon, Dilip Patel, Anthony Wackett, Michelle Steven, Fenella Welsh, Myrddin Rees, HepaT1ca Study Group, Damian J Mole, Jonathan A Fallowfield, Ahmed E Sherif, Timothy Kendall, Scott Semple, Matt Kelly, Gerard Ridgway, John J Connell, John McGonigle, Rajarshi Banerjee, J Michael Brady, Xiaozhong Zheng, Michael Hughes, Lucile Neyton, Joanne McClintock, Garry Tucker, Hilary Nailon, Dilip Patel, Anthony Wackett, Michelle Steven, Fenella Welsh, Myrddin Rees, HepaT1ca Study Group
Abstract
The risk of poor post-operative outcome and the benefits of surgical resection as a curative therapy require careful assessment by the clinical care team for patients with primary and secondary liver cancer. Advances in surgical techniques have improved patient outcomes but identifying which individual patients are at greatest risk of poor post-operative liver performance remains a challenge. Here we report results from a multicentre observational clinical trial (ClinicalTrials.gov NCT03213314) which aimed to inform personalised pre-operative risk assessment in liver cancer surgery by evaluating liver health using quantitative multiparametric magnetic resonance imaging (MRI). We combined estimation of future liver remnant (FLR) volume with corrected T1 (cT1) of the liver parenchyma as a representation of liver health in 143 patients prior to treatment. Patients with an elevated preoperative liver cT1, indicative of fibroinflammation, had a longer post-operative hospital stay compared to those with a cT1 within the normal range (6.5 vs 5 days; p = 0.0053). A composite score combining FLR and cT1 predicted poor liver performance in the 5 days immediately following surgery (AUROC = 0.78). Furthermore, this composite score correlated with the regenerative performance of the liver in the 3 months following resection. This study highlights the utility of quantitative MRI for identifying patients at increased risk of poor post-operative liver performance and a longer stay in hospital. This approach has the potential to inform the assessment of individualised patient risk as part of the clinical decision-making process for liver cancer surgery.
Conflict of interest statement
I have read the journal’s policy and the authors of this manuscript have the following competing interests: MK, GR, JJC, JMcG, RB, and JMB are employees and shareholders at Perspectum Ltd. This does not alter our adherence to PLOS ONE policies on sharing data and materials. There are no other actual or perceived conflicts of interest to declare.
Figures
References
- Krell RW, D’Angelica MI. Treatment sequencing for simultaneous colorectal liver metastases. J Surg Oncol. 2019. April;119(5):583–93. 10.1002/jso.25424
- Villanueva A. Hepatocellular Carcinoma. N Engl J Med. 2019. 11;380(15):1450–62. 10.1056/NEJMra1713263
- Adam R, Kitano Y. Multidisciplinary approach of liver metastases from colorectal cancer. Ann Gastroenterol Surg. 2019. January 14;3(1):50–6. 10.1002/ags3.12227
- Hyder O, Pulitano C, Firoozmand A, Dodson R, Wolfgang CL, Choti MA, et al. A risk model to predict 90-day mortality among patients undergoing hepatic resection. J Am Coll Surg. 2013. June;216(6):1049–56. 10.1016/j.jamcollsurg.2013.01.004
- Suzuki K, Epstein ML, Kohlbrenner R, Garg S, Hori M, Oto A, et al. Quantitative Radiology: Automated CT Liver Volumetry Compared With Interactive Volumetry and Manual Volumetry. AJR Am J Roentgenol. 2011. October;197(4):W706–12. 10.2214/AJR.10.5958
- Amptoulach S, Gross G, Kalaitzakis E. Differential impact of obesity and diabetes mellitus on survival after liver resection for colorectal cancer metastases. J Surg Res. 2015. December;199(2):378–85. 10.1016/j.jss.2015.05.059
- Little SA, Jarnagin WR, DeMatteo RP, Blumgart LH, Fong Y. Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer. J Gastrointest Surg. 2002. February;6(1):88–94. 10.1016/s1091-255x(01)00019-1
- Rahnemai-Azar AA, Cloyd JM, Weber SM, Dillhoff M, Schmidt C, Winslow ER, et al. Update on Liver Failure Following Hepatic Resection: Strategies for Prediction and Avoidance of Post-operative Liver Insufficiency. J Clin Transl Hepatol. 2018. March 28;6(1):97–104. 10.14218/JCTH.2017.00060
- Rassam F, Olthof PB, Richardson H, van Gulik TM, Bennink RJ. Practical guidelines for the use of technetium-99m mebrofenin hepatobiliary scintigraphy in the quantitative assessment of liver function. Nucl Med Commun. 2019. April;40(4):297–307. 10.1097/MNM.0000000000000973
- Haimerl M, Probst U, Poelsterl S, Beyer L, Fellner C, Selgrad M, et al. Hepatobiliary MRI: Signal intensity based assessment of liver function correlated to 13 C-Methacetin breath test. Scientific Reports. 2018. June 13;8(1):1–8.
- Wang L, Xie L, Zhang N, Zhu W, Zhou J, Pan Q, et al. Predictive Value of Intraoperative Indocyanine Green Clearance Measurement on Postoperative Liver Function After Anatomic Major Liver Resection. J Gastrointest Surg. 2019. June 13; 10.1007/s11605-019-04262-5
- Cheung TT, Han H-S, She WH, Chen K-H, Chow PKH, Yoong BK, et al. The Asia Pacific Consensus Statement on Laparoscopic Liver Resection for Hepatocellular Carcinoma: A Report from the 7th Asia-Pacific Primary Liver Cancer Expert Meeting Held in Hong Kong. Liver Cancer. 2018. March;7(1):28–39. 10.1159/000481834
- Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The “50–50 Criteria” on Postoperative Day 5. Ann Surg. 2005. December;242(6):824–9. 10.1097/01.sla.0000189131.90876.9e
- van Mierlo KMC, Lodewick TM, Dhar DK, van Woerden V, Kurstjens R, Schaap FG, et al. Validation of the peak bilirubin criterion for outcome after partial hepatectomy. HPB (Oxford). 2016. October;18(10):806–12. 10.1016/j.hpb.2016.06.003
- Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg. 2008. January;247(1):49–57. 10.1097/SLA.0b013e31815f6e5b
- Kawaguchi Y, Lillemoe HA, Vauthey J-N. Dealing with an insufficient future liver remnant: Portal vein embolization and two-stage hepatectomy. J Surg Oncol. 2019. April;119(5):594–603. 10.1002/jso.25430
- Olthof PB, van Dam R, Jovine E, Campos RR, de Santibañes E, Oldhafer K, et al. Accuracy of estimated total liver volume formulas before liver resection. Surgery. 2019;166(3):247–53. 10.1016/j.surg.2019.05.003
- Duwe G, Knitter S, Pesthy S, Beierle AS, Bahra M, Schmelzle M, et al. Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection. Eur J Surg Oncol. 2017. September;43(9):1668–81. 10.1016/j.ejso.2017.05.008
- Pavlides M, Banerjee R, Tunnicliffe EM, Kelly C, Collier J, Wang LM, et al. Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity. Liver Int. 2017;37(7):1065–73. 10.1111/liv.13284
- McDonald N, Eddowes PJ, Hodson J, Semple SIK, Davies NP, Kelly CJ, et al. Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study. Sci Rep. 2018. 15;8(1):9189 10.1038/s41598-018-27560-5
- Banerjee R, Pavlides M, Tunnicliffe EM, Piechnik SK, Sarania N, Philips R, et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol. 2014. January;60(1):69–77. 10.1016/j.jhep.2013.09.002
- Pavlides M, Banerjee R, Sellwood J, Kelly CJ, Robson MD, Booth JC, et al. Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease. J Hepatol. 2016. February;64(2):308–15. 10.1016/j.jhep.2015.10.009
- Eddowes PJ, McDonald N, Davies N, Semple SIK, Kendall TJ, Hodson J, et al. Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2018;47(5):631–44. 10.1111/apt.14469
- Harrison SA, Rossi SJ, Paredes AH, Trotter JF, Bashir MR, Guy CD, et al. NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients with Nonalcoholic Steatohepatitis. Hepatology. 2019. February 25 10.1002/hep.30590
- Mole DJ, Fallowfield JA, Kendall TJ, Welsh F, Semple SI, Bachtiar V, et al. Study protocol: HepaT1ca—an observational clinical cohort study to quantify liver health in surgical candidates for liver malignancies. BMC Cancer. 2018. September 12;18(1):890 10.1186/s12885-018-4737-3
- Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009. April;42(2):377–81. 10.1016/j.jbi.2008.08.010
- Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019. July;95:103208 10.1016/j.jbi.2019.103208
- Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005. June;41(6):1313–21. 10.1002/hep.20701
- Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995. June;22(6):696–9. 10.1016/0168-8278(95)80226-6
- Owler J, Irving B, Ridgway G, Wojciechowska M, McGonigle J, Brady M. Comparison of Multi-atlas Segmentation and U-Net Approaches for Automated 3D Liver Delineation in MRI. In: [Internet]. 2020 [cited 2020 Mar 16].
- Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage. 2006. July 1;31(3):1116–28. 10.1016/j.neuroimage.2006.01.015
- Couinaud C. [Liver lobes and segments: notes on the anatomical architecture and surgery of the liver]. Presse Med. 1954. May 5;62(33):709–12.
- Germain T, Favelier S, Cercueil J-P, Denys A, Krausé D, Guiu B. Liver segmentation: practical tips. Diagn Interv Imaging. 2014. November;95(11):1003–16. 10.1016/j.diii.2013.11.004
- Mojtahed A, Kelly CJ, Herlihy AH, Kin S, Wilman HR, McKay A, et al. Reference range of liver corrected T1 values in a population at low risk for fatty liver disease—a UK Biobank sub-study, with an appendix of interesting cases. Abdom Radiol. 2019. January 1;44(1):72–84.
- Jayaswal A, Levick C, Selvaraj E, Dennis A, Booth J, Collier J, et al. Prognostic value of multiparametric MRI, transient elastography and serum fibrosis markers in patients with chronic liver disease. Liver International. 2020;(Accepted for publication). 10.1111/liv.14625
- Lorenzo CSF, Limm WML, Lurie F, Wong LL. Factors affecting outcome in liver resection. HPB (Oxford). 2005;7(3):226–30. 10.1080/13651820510028864
- Han EC, Ryoo S-B, Park JW, Yi JW, Oh H-K, Choe EK, et al. Oncologic and surgical outcomes in colorectal cancer patients with liver cirrhosis: A propensity-matched study. PLoS One [Internet]. 2017. June 6 [cited 2020 Mar 30];12(6). Available from:
- Abu Hilal M, Di Fabio F, Syed S, Wiltshire R, Dimovska E, Turner D, et al. Assessment of the financial implications for laparoscopic liver surgery: a single-centre UK cost analysis for minor and major hepatectomy. Surg Endosc. 2013. July 1;27(7):2542–50. 10.1007/s00464-012-2779-1
- van Beek D, Funaki B. Hemorrhage as a Complication of Percutaneous Liver Biopsy. Semin Intervent Radiol. 2013. December;30(4):413–6. 10.1055/s-0033-1359737
- Di Tommaso L, Spadaccini M, Donadon M, Personeni N, Elamin A, Aghemo A, et al. Role of liver biopsy in hepatocellular carcinoma. World J Gastroenterol. 2019. October 28;25(40):6041–52. 10.3748/wjg.v25.i40.6041
- Tan M, Xu F-F, Peng J-S, Li D-M, Chen L-H, Lv B-J, et al. Changes in the level of serum liver enzymes after laparoscopic surgery. World J Gastroenterol. 2003. February 15;9(2):364–7. 10.3748/wjg.v9.i2.364
- Gilgenkrantz H, Collin de l’Hortet A. Understanding Liver Regeneration: From Mechanisms to Regenerative Medicine. The American Journal of Pathology. 2018. June 1;188(6):1316–27. 10.1016/j.ajpath.2018.03.008
- Sturesson C, Nilsson J, Eriksson S, Spelt L, Andersson R. Limiting factors for liver regeneration after a major hepatic resection for colorectal cancer metastases. HPB (Oxford). 2013. August;15(8):646–52.
Source: PubMed